Total Payments
$130,291
2024 Payments
$4,223
Companies
36
Transactions
653
Medicare Patients
751
Medicare Billing
$56,327
Payment Breakdown by Category
Other$79,147 (60.7%)
Consulting$26,035 (20.0%)
Food & Beverage$14,877 (11.4%)
Travel$10,017 (7.7%)
Education$213.90 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $79,147 | 63 | 60.7% |
| Consulting Fee | $26,035 | 18 | 20.0% |
| Food and Beverage | $14,877 | 536 | 11.4% |
| Travel and Lodging | $10,017 | 32 | 7.7% |
| Education | $213.90 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $63,535 | 102 | $0 (2023) |
| Allergan, Inc. | $30,598 | 146 | $0 (2023) |
| ABBVIE INC. | $24,187 | 137 | $0 (2024) |
| Merz North America, Inc. | $7,389 | 43 | $0 (2023) |
| Janssen Biotech, Inc. | $919.14 | 60 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $455.87 | 26 | $0 (2024) |
| REVANCE THERAPEUTICS, INC. | $444.59 | 14 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $315.65 | 12 | $0 (2024) |
| LEO Pharma Inc. | $270.87 | 13 | $0 (2023) |
| Lilly USA, LLC | $247.74 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,223 | 65 | ABBVIE INC. ($3,193) |
| 2023 | $26,138 | 97 | AbbVie Inc. ($20,319) |
| 2022 | $22,948 | 95 | Galderma Laboratories, L.P. ($17,510) |
| 2021 | $21,570 | 87 | Galderma Laboratories, L.P. ($12,248) |
| 2020 | $7,634 | 40 | Allergan, Inc. ($6,478) |
| 2019 | $5,815 | 77 | Allergan Inc. ($3,926) |
| 2018 | $14,155 | 85 | Galderma Laboratories, L.P. ($12,008) |
| 2017 | $27,808 | 107 | Galderma Laboratories, L.P. ($16,977) |
All Payment Transactions
653 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $18.44 | General |
| 12/11/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $151.84 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/22/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Immunology | ||||||
| 11/20/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/12/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 10/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/22/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $15.95 | General |
| 10/18/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $51.50 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 10/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.06 | General |
| Category: Immunology | ||||||
| 10/15/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 10/07/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Dermatology | ||||||
| 10/04/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $132.63 | General |
| 10/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/26/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $18.83 | General |
| 09/26/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $18.83 | General |
| 09/19/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $29.92 | General |
| Category: Dermatology | ||||||
| 09/06/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $531.60 | General |
| 08/27/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Dermatology | ||||||
| 08/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.14 | General |
| Category: Immunology | ||||||
| 08/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: FACIAL AESTHETICS | ||||||
| 08/01/2024 | Lilly USA, LLC | TALTZ (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Immunology | ||||||
| 07/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: IMMUNOLOGY | ||||||
| 07/17/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $80.29 | General |
| Category: FACIAL AESTHETICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 189 | 325 | $43,562 | $14,002 |
| 2022 | 6 | 154 | 231 | $30,671 | $11,253 |
| 2021 | 7 | 219 | 332 | $48,214 | $18,281 |
| 2020 | 6 | 189 | 304 | $39,372 | $12,790 |
Total Patients
751
Total Services
1,192
Medicare Billing
$56,327
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 64 | $12,147 | $4,198 | 34.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 23 | 28 | $7,794 | $2,645 | 33.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 22 | $6,186 | $2,138 | 34.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 22 | 25 | $6,153 | $1,827 | 29.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 34 | 44 | $6,907 | $1,657 | 24.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 18 | $2,316 | $812.49 | 35.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 26 | 124 | $2,059 | $725.82 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 48 | 57 | $8,778 | $3,634 | 41.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 24 | 26 | $5,902 | $2,733 | 46.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 22 | 24 | $5,112 | $1,768 | 34.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 18 | 20 | $4,840 | $1,603 | 33.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 28 | 35 | $4,935 | $1,153 | 23.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 14 | 69 | $1,104 | $362.43 | 32.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 62 | 87 | $13,398 | $6,400 | 47.8% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 30 | 36 | $8,712 | $3,247 | 37.3% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 35 | 37 | $7,881 | $2,524 | 32.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 21 | $4,767 | $2,133 | 44.7% |
| 11104 | Punch biopsy of single skin lesion | Office | 2021 | 19 | 20 | $5,360 | $1,969 | 36.7% |
| 17000 | Destruction of skin growth | Office | 2021 | 36 | 48 | $6,768 | $1,612 | 23.8% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 19 | 83 | $1,328 | $396.35 | 29.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 40 | 48 | $10,896 | $3,875 | 35.6% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 29 | 33 | $7,986 | $2,670 | 33.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 36 | 42 | $6,468 | $2,418 | 37.4% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 30 | 33 | $7,029 | $1,968 | 28.0% |
| 17000 | Destruction of skin growth | Office | 2020 | 31 | 37 | $5,217 | $1,308 | 25.1% |
About Dr. Jacqueline Calkin, M.D
Dr. Jacqueline Calkin, M.D is a Dermatology healthcare provider based in Sacramento, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871561589.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jacqueline Calkin, M.D has received a total of $130,291 in payments from pharmaceutical and medical device companies, with $4,223 received in 2024. These payments were reported across 653 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($79,147).
As a Medicare-enrolled provider, Calkin has provided services to 751 Medicare beneficiaries, totaling 1,192 services with total Medicare billing of $56,327. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Sacramento, CA
- Active Since 03/09/2006
- Last Updated 03/08/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1871561589
Products in Payments
- BOTOX COSMETIC (Biological) $4,564
- Asclera (Drug) $825.00
- BOTOX (Biological) $686.97
- ASCLERA (Drug) $550.00
- DAXXIFY (Drug) $444.59
- TREMFYA (Drug) $425.71
- SKYRIZI (Biological) $400.68
- Humira (Biological) $296.97
- Tremfya (Drug) $260.11
- COSENTYX (Biological) $257.42
- DUPIXENT (Biological) $248.13
- COSENTYX (Drug) $180.77
- Enbrel (Biological) $175.04
- OPZELURA (Drug) $167.70
- STELARA (Biological) $164.55
- Winlevi (Drug) $164.08
- XEOMIN (Biological) $163.96
- ADBRY (Biological) $154.41
- HUMIRA (Biological) $152.24
- TALTZ (Drug) $121.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Sacramento
Dr. Raja Sivamani, M.d., M.s., A.h.e, M.D., M.S., A.H.E
Dermatology — Payments: $1.3M
Dermatology $1.3M
Dr. Emil Tanghetti, M.d, M.D
Dermatology — Payments: $1.0M
Dermatology $1.0M
Dr. Emanual Maverakis, M.d, M.D
Dermatology — Payments: $52,284
Dermatology $52,284
Alison Boudreaux, M.d, M.D
Dermatology — Payments: $46,728
Dermatology $46,728
Mirza Alikhan, Md, MD
Dermatology — Payments: $30,111
Dermatology $30,111
Jennifer Ornelas
Dermatology — Payments: $28,781
Dermatology $28,781